Skip to main content

Table 4 Univariate analysis of 5-year survival

From: Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis

Variable Univariable survival analysis [n (%)]
Survival (n = 30) Death (n = 67) X2 p-value
Age < 60 19 (63.33) 30 (44.78) 4.912 0.027
≥ 60 11 (36.67) 37 (55.22)
Sex Male 24 (80.00) 50 (74.63) 0.056 0.813
Female 6 (20.00) 17 (25.37)
Tumor diameter < 4.0 19 (63.33) 29 (43.28) 6.681 0.009
≥ 4.0 11 (36.67) 38 (56.72)
Tumor location Gastric body 3 (10.00) 11 (16.42) 2.503 0.286
Gastric antrum 20 (66.67) 48 (71.64)
Gastric fundus 7 (23.33) 8 (11.94)
Operation method Distal gastrectomy 20 (66.67) 46 (68.66) 1.81 0.405
Proximal gastrectomy 6 (20.00) 10 (14.93)
Total gastrectomy 4 (13.33) 11 (16.42)
Clinicopathologic stage I–II 23 (76.67) 24 (35.82) 22.32 < 0.001
III–IV 7 (23.33) 43 (64.18)
Differentiated degree Poor differentiation 13 (43.33) 41 (61.19) 3.902 0.142
Moderate differentiation 15 (50.00) 23 (34.33)
High differentiation 2 (6.67) 3 (4.48)
c-Met expression Low expression 16 (53.33) 18 (26.87) 7.929 0.005
High expression 14 (46.67) 49 (73.13)
HER2-IHC Negative 29 (96.67) 58 (89.23) 1.913 0.167
Positive 1 (3.33) 7 (10.77)
AFP (ng/ml) < 2.54 7 (28.00) 17 (32.08) 8.92 0.002
≥ 2.54 18 (72.00) 36 (67.92)
CEA (ng/ml) < 2.13 11 (44.00) 28 (52.83) 0.845 0.358
≥ 2.13 14 (56.00) 25 (47.17)
CA199 (μ/ml) < 12.78 13 (52.00) 15 (28.30) 0.448 0.503
≥ 12.78 12 (48.00) 38 (71.70)
CA153 (μ/ml) < 7.70 15 (60.00) 23 (44.23) 1.023 0.312
≥ 7.70 10 (40.00) 29 (55.77)
CA125 (μ/ml) < 6.80 13 (54.17) 25 (47.17) 0.055 0.814
≥ 6.80 11 (45.83) 28 (52.83)
CA50 (μ/ml) < 4.53 12 (50.00) 25 (49.02) 0.137 0.711
≥ 4.53 12 (50.00) 26 (50.98)
H. pylori Negative 10 (45.45) 27 (51.92) 0.427 0.514
Positive 12 (54.55) 25 (48.08)